scholarly journals Litigating Federal Health Care Legislation and the Interstices of Procedure,

2018 ◽  
Author(s):  
Wendy Collins Perdue

Forward to the 2012 Allen Chair Symposium issue, focused on the litigation challenges to the Patient Protection and Affordable Care Act ("ACA").

2017 ◽  
Vol 32 (4) ◽  
pp. 906-915 ◽  
Author(s):  
Ashlee N. Sawyer ◽  
Melissa A. Kwitowski ◽  
Eric G. Benotsch

Purpose: Sexual and reproductive health conditions (eg, infections, cancers) represent public health concerns for American women. The present study examined how knowledge of the Patient Protection and Affordable Care Act (PPACA) relates to receipt of preventive reproductive health services among women. Design: Cross-sectional online survey. Setting: Online questionnaires were completed via Amazon Mechanical Turk, a crowdsourcing website where individuals complete web-based tasks for compensation. Participants: Cisgendered women aged 18 to 44 years (N = 1083) from across the United States. Measures: Participants completed online questionnaires assessing demographics, insurance status, preventive service use, and knowledge of PPACA provisions. Analysis: Chi-squares showed that receipt of well-woman, pelvic, and breast examinations, as well as pap smears, was related to insurance coverage, with those not having coverage at all during the previous year having significantly lower rates of use. Hierarchical logistic regressions determined the independent relationship between PPACA knowledge and use of health services after controlling for demographic factors and insurance status. Results: Knowledge of PPACA provisions was associated with receiving well-woman, pelvic, and breast examinations, human papillomavirus vaccination, and sexually transmitted infections testing, after controlling for these factors. Results indicate that expanding knowledge about health-care legislation may be beneficial in increasing preventive reproductive health service use among women. Conclusion: Current findings provide support for increasing resources for outreach and education of the general population about the provisions and benefits of health-care legislation, as well as personal health coverage plans.


Author(s):  
Shuang Qin Zhang ◽  
Blase N. Polite

The Patient Protection and Affordable Care Act (ACA) was signed into law by President Barack Obama on March 23, 2010. Since that time, numerous regulations have been promulgated, legal battles continue to be fought and the major provisions of the law are being implemented. In the following article, we outline components of the ACA that are relevant to cancer health care, review current implementation of the new health care reform law, and identify challenges that may lie ahead in the post-ACA era. Specifically, among the things we explore are Medicaid expansion, health insurance exchanges, essential health benefits and preventive services, subsidies, access to clinical trials, the Medicare Part D donut hole, and physician quality payment reform.


2019 ◽  
Vol 81 (2) ◽  
pp. 631-634 ◽  
Author(s):  
Raghav Tripathi ◽  
Konrad D. Knusel ◽  
Harib H. Ezaldein ◽  
Jeremy S. Bordeaux ◽  
Jeffrey F. Scott

Author(s):  
Bradley Herring ◽  
Lisa Korin Lentz

One controversial aspect of the Patient Protection and Affordable Care Act is the provision to impose a 40% excise tax on insurance benefits above a certain threshold, commonly referred to as the “Cadillac tax.” We use the Employer Health Benefits Survey, sponsored by the Kaiser Family Foundation and Health Research and Educational Trust, to examine the number and characteristics of plans that likely will be affected. We estimate that about 16% of plans will incur the tax upon implementation in 2018, while about 75% of plans will incur the tax a decade later due to the indexing of the tax thresholds with the Consumer Price Index. If the Cadillac tax is ultimately implemented as written, we find that it will likely reduce private health care benefits by .7% in 2018 and 3.1% in 2029, and will likely raise about $931 billion in revenue over the ensuing 10-year budget window from 2020 to 2029.


SAGE Open ◽  
2016 ◽  
Vol 6 (1) ◽  
pp. 215824401663618
Author(s):  
Victor Eno ◽  
Senthilkumar Mehalingam ◽  
Thomas I. Nathaniel

2015 ◽  
Vol 4 (1) ◽  
pp. 27
Author(s):  
Cheryl Ann Alexander ◽  
Lidong Wang

<p>The purpose of this paper is to examine several key issues in health care reform. From the Patient Protection and Affordable Care Act of 2010 to the cholera epidemic in Haiti, global health care reform is necessary to promote health and wellness among all nations. There is an international shortage of nurses and nursing faculty. Among the providers, it is also necessary to examine autonomy of the most up and coming nurse provider: the emergency nurse practitioner.</p>


Author(s):  
Beverly Moy ◽  
Amy P. Abernethy ◽  
Jeffrey M. Peppercorn

Overview: The Affordable Care Act (ACA) contains many provisions that affect cancer care. The provisions of health care reform aim to improve access to quality cancer care, particularly among the most vulnerable Americans. However, health care reform also offers many challenges and opportunities that affect every stakeholder in oncology. This article summarizes the ACA provisions relevant to oncology, discusses the ethical implications for the oncology caregiver, and describes the effects on specific oncology stakeholders.


Author(s):  
Kavita K. Patel ◽  
Lisa Tran

The Patient Protection and Affordable Care Act (ACA) contains within it three significant legislative constructs: to enhance access to health care, improve quality, and decrease cost. Also known as the Triple Aim, these three simple, yet monumental, goals have been the object of actions to date as well as future implementation efforts. This article will identify sections of the legislation that would directly provide areas of opportunity to improve health and achieve the triple aim for the oncology profession.


2015 ◽  
Vol 53 (2) ◽  
pp. 235-284 ◽  
Author(s):  
Martin Gaynor ◽  
Kate Ho ◽  
Robert J. Town

The U.S. health-care sector is large and growing—health-care spending in 2011 amounted to $2.7 trillion and 18 percent of GDP. Approximately half of health-care output is allocated via markets. In this paper, we analyze the industrial organization literature on health-care markets, focusing on the impact of competition on price, quality, and treatment decisions for health-care providers and health insurers. We conclude with a discussion of research opportunities for industrial organization economists, including opportunities created by the U.S. Patient Protection and Affordable Care Act. (JEL J15, J24, J71, J81, K31)


Sign in / Sign up

Export Citation Format

Share Document